Literature DB >> 15459475

Gadopentetate dimeglumine as a potential alternative contrast medium during percutaneous coronary intervention: a case report.

Shinichi Furuichi1, Satoshi Yasuda, Yukio Arita, Masami Miyawaki, Kei Nomura, Hiroshi Nonogi, Takashi Shindo.   

Abstract

BACKGROUND: There have not been previous reports of patients undergoing percutaneous coronary intervention (PCI) using a gadolinium chelate. METHODS AND
RESULTS: A 74-year-old woman, who had a history of anaphylactic shock 4 times in response to iodinated contrast media despite preprocedural intravenous administration of hydrocortisone, was hospitalized because of unstable angina refractory to intensive medical treatment. Fully considering the risks of iodinated agents, digital subtraction coronary angiography and PCI were performed using gadopentetate dimeglumine without any side effects or complications.
CONCLUSIONS: Gadolinium chelates can be an alternative contrast media during PCI in particular patients with contraindications to iodinated media.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15459475     DOI: 10.1253/circj.68.972

Source DB:  PubMed          Journal:  Circ J        ISSN: 1346-9843            Impact factor:   2.993


  2 in total

1.  Determination of infarct size in ex vivo swine hearts by multidetector computed tomography using gadolinium as contrast medium.

Authors:  Akos Varga-Szemes; Balazs Ruzsics; Robert Kirschner; Satinder P Singh; Pal Kiss; Brigitta C Brott; Tamas Simor; Ada Elgavish; Gabriel A Elgavish
Journal:  Invest Radiol       Date:  2012-05       Impact factor: 6.016

2.  Successful balloon pulmonary angioplasty with gadolinium contrast media for a patient with chronic thromboembolic pulmonary hypertension and iodine allergy.

Authors:  Tomohisa Nakamura; Takeshi Ogo; Akihiro Tsuji; Shigefumi Fukui; Tetsuya Fukuda; Nobuhiro Tahara; Yoshihiro Fukumoto; Satoshi Yasuda; Hisao Ogawa; Norifumi Nakanishi
Journal:  Respir Med Case Rep       Date:  2016-02-08
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.